Burke:
Overview
This article provides an evidence-based review of the diagnostic assessment for DSM-5 Disruptive, Impulse Control, and Conduct Disorders (DBDs): Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), Antisocial Personality Disorder (APD), and Intermittent Explosive Disorder (IED).
It also discusses disruptive mood dysregulation disorder (DMDD) and key dimensions of ODD and CD due to their relevance for assessing DBDs.
Main message: use multiple information sources (e.g., clinical interview, standardized rating scales/checklists) and multiple informants (e.g., parent, teacher, self-report) to reduce biases and improve diagnostic accuracy; follow diagnostic guidelines closely; be mindful of stigma, trauma history, race and gender biases; and consider dimensional versus categorical approaches.
Key Concepts and Definitions
Disruptive behavior disorders (DBDs) include ODD, CD, APD, IED; DMDD is discussed due to overlap with irritability dimensions.
Core feature across DBDs: harmful behaviors toward others or norms, with nuanced distinctions:
ODD: chronic oppositional behavior and hostile/irritable interpersonal interactions; aggression is not required.
CD: must include aggressive behaviors plus property damage, theft, or rule violations; includes deficits in prosocial emotions (LPE).
APD: pervasive disregard for others and societal norms; may include impulsivity, irresponsibility, fights; requires age 18+ with prior evidence of conduct problems before age 15.
IED: intense, reactive aggressive outbursts; not other DBD symptoms predominating.
DMDD: chronic irritability and severe temper outbursts; overlaps with ODD; distinct considerations in assessment and cross-diagnostic context.
DSM-5 vs ICD-11: ICD-11 includes chronic irritability/anger as a potential subtype/feature within ODD; DSM-5 discourages a formal chronic irritability syndrome within ODD, though irritability is a key dimension.
Four core dimensions proposed for early irritability and behavior (dimension-based approach): noncompliance, irritability, aggression, callousness; dimensional models may better capture heterogeneity than strict categories, though evidence is mixed on whether dimensional models outperform categorical diagnoses in practice.
Important empirical points:
There is substantial overlap among DBDs and with other disorders (e.g., DMDD, ADHD, mood disorders) and with risk factors (trauma, family history).
Stigma around DBDs is debated; empirical evidence for diagnosable harm from DSM labeling is limited, but clinicians should be mindful of potential bias and costs/benefits of labeling.
Multi-informant data improve assessment; informant discrepancies reflect context differences and are informative rather than purely erroneous.
Assessment should be developmentally appropriate and sensitive to lifespan changes (ODD/CD seen in preschool to adulthood; DMDD developmentally anchored in childhood).
Key numerical references (examples):
CD criteria:
ODD: DSM-5 criteria are organized under three headings: Angry/Irritable Mood, Argumentative/Defiant Behavior, and Vindictiveness.
DMDD prevalence estimates span a wide range:
Lifetime prevalence of CD:
Lifetime prevalence of ODD: epidemiological data place lifetime prevalence around roughly $10.2\%$ (Nock et al., 2007).
IED lifetime prevalence:
ODD test–retest reliability for diagnostic interviews: parent interview $k = 0.59$; child interview $k = 0.39$ (higher reliability when including parent/caregiver input).
APD prevalence in adults: roughly $3\%$ to $5\%$, with a subset of individuals showing broader psychopathic traits; race and sex differences exist in measurement and prevalence.
Diagnostic tools and measures are organized by disorder and by purpose (interviews vs. rating scales vs. multi-informant instruments). Specific tools are listed in Tables 1 and 2 of the article; here we summarize representative examples.
Factors Affecting Clinical Judgment in DBD Assessment
Stigma
Clinician concern: labeling may stigmatize; empirical evidence for actual harm from diagnosis is limited, though perceptions influence clinical practice.
Some research suggests stigma is more evident when diagnoses combine behavioral and emotional disorders rather than behavioral disorders alone.
Benefits of diagnosis include access to evidence-based treatment, prognosis, and academic supports; research is needed to quantify real-world costs and benefits of labeling.
Trauma (potential traumatic events, PTEs)
Clinician belief that behavioral disorders are trauma-driven can bias judgment.
Be mindful that trauma is a risk factor for DBDs and that DBDs and PTSD can co-occur; the presence of trauma should not rule out a DBD diagnosis.
Ethical approach: complete, accurate diagnostic assessment including DBDs when appropriate.
Racial Bias in Diagnostic Practice
Minority youths may be misdiagnosed with DBDs more often, with alternative diagnoses (e.g., ADHD, autism, mood disorders) sometimes more appropriate.
Race concordance between clinician and patient may mitigate or exacerbate bias; education and targeted bias-reduction strategies are recommended.
Strategies to reduce bias include education, training activities, and systemic interventions; training and evidence-based assessment are needed to improve reliability/validity.
Gender Bias in Diagnostic Practice
Historically more DBD diagnoses in males (e.g., CD), though symptom patterns and aggression levels may differ by gender.
Clinicians should adhere to DSM-5 criteria and be cautious of unconscious gender beliefs; algorithmic and statistical approaches may help reduce bias.
Practical implication: biases can distort the diagnostic process, but with explicit attention to guidelines, multi-informant data, and robust assessment methods, clinicians can mitigate bias and improve accuracy.
General Assessment Best Practices for DBDs
Diagnostic assessment should be a multistep process:
Clarify the purpose of the assessment (e.g., treatment planning, differential diagnosis).
Develop a diagnostic formulation that informs case conceptualization and treatment planning.
Recognize that diagnoses are helpful but not always central to understanding presenting problems; not all symptoms meet criteria for a diagnosis or are clinically central.
Screen out diagnoses or consider differential diagnoses when warranted; consider sleep, stress, and wellness behaviors that affect functioning.
Standards for assessment in the field:
Clinicians must integrate information across sources to produce a sound diagnostic formulation; many clinicians still do not consistently reference guidelines.
Large-scale data indicate a substantial proportion of clinicians provide diagnoses without consulting diagnostic guidelines, highlighting a gap between practice and evidence-based standards.
Clinical practice must be anchored in empirical knowledge about comorbidities and development, not just clinical intuition.
Assessment Methods (overview):
Use behavioral rating scales and structured/semi-structured diagnostic interviews to obtain broad symptom coverage and to increase identified diagnoses compared with unstructured interviews.
Training and time considerations exist for standardized interviews; one practical approach is to use rating scales first to screen areas of concern, then administer targeted interview modules.
Tables 1 and 2 in the article list tools for ODD, CD, LPE, DMDD, APD, and IED (interviews and rating scales).
Informant Effects and Multi-Informant Assessment
Informants (parents, teachers, self-report) often show low interrater agreement; this is not merely measurement error but may reflect genuine context differences.
Collecting information from multiple informants enhances assessment; discrepancies can be informative for prognosis and treatment planning.
If criteria are met based on a single informant, the information still carries prognostic risk and should not be discounted.
In children, parents and teachers provide complementary views; in adults, collateral informants (e.g., partners, coworkers) can be more challenging to obtain but valuable.
Informant integration and measurement considerations:
Use a combination of interviews and rating scales to maximize coverage and efficiency.
Consider developmentally appropriate methods across the lifespan (preschool, school-age, adolescence, adulthood).
Informant- and method-related evidence bases:
A large body of work supports multi-informant approaches and convergent validity across informants when integrated properly.
The literature emphasizes the need for developmentally sensitive measures and cross-informant data integration, particularly for DMDD and irritability dimensions.
Tools: a snapshot of assessment options (representative examples from Tables 1 and 2):
Interviews (ODD and related): CAPA (Angold & Costello, 2000); CHIPS (Weller et al., 2000); DAWBA (Developmental and Well-Being Assessment); DICA-PPYC; DIPA; DISCAP-5; K-SADS-PL-5; MINI KID; PAPA; WRAADS.
Prosocial Emotions (LPE) related: CAPE; M-LPE.
Rating scales for ODD/CD/LPE: ABI-YA; ASROS-5; CABI; CASI-5; DBDRS; K-CAT; NICHQ Vanderbilt; SNAP-IV; CPTI; PSCD.
Summary observation: parent/teacher reports often show high utility for cross-informant screening and differential diagnosis.
Dimensionality vs discrete categories (revisited)
Categorical diagnoses provide clear clinical decision utility (e.g., treatment matching).
Dimensional models may capture heterogeneity within and across disorders, with proposed models (e.g., Wakschlag et al., 2017) highlighting noncompliance, irritability, aggression, and callousness as core dimensions.
Empirical evidence on whether dimensional models outperform categorical models is mixed (ambiguous results in Krueger et al., 2021; Thöne et al., 2022).
For ODD in particular, dimensions (irritable vs. defiant) have shown prognostic relevance, but guidance on chronic irritability within ODD remains limited; ICD-11 provides more explicit irritability-based distinctions within ODD.
Oppositional Defiant Disorder (ODD)
DSM-5 criteria and structure
DSM-5 organizes ODD symptoms under three categories: Angry/Irritable Mood; Argumentative and Defiant Behavior; Vindictiveness.
ODD criteria emphasize irritability and defiant behaviors; aggression is not required, but irritability has prognostic utility for internalizing and externalizing outcomes.
DSM-5 does not specify subtypes within ODD, though ICD-11 includes irritability-based subtypes.
Dimensional considerations for ODD
Distinguishing irritable vs. defiant symptom dimensions is supported by factor-analytic work; these dimensions may have different prognostic implications (e.g., risk for depression/anxiety versus antisocial behavior).
In preschool-aged children, dimensional approaches can help identify chronic irritability and its treatment implications; however, no clear empirical guideline dictates a categorical vs dimensional cutoff for irritability within ODD.
Diagnostic Interviews for ODD
Widely used interviews: K-SADS-PL-5; CAPA; DISK/DISCAP-5; DIPA; PAPA; PAPA; WRAADS; others.
Web-based self-admin versions for parent/child reports have shown promising psychometric properties (e.g., K-SADS-PL-5 web versions).
In many cases, DSM-IV interviews remain acceptable when updating to DSM-5 standards; nonetheless, DSM-5-compatible instruments are preferred.
Rating Scales for ODD
Notable tools: CABI; CASI-5; DBDRS; Swanson, Nolan, and Pelham Rating Scale (SNAP-IV); K-CAT (Kiddie Computerized Adaptive Test) for rapid dimensional assessment; NICHQ Vanderbilt scales.
CABI has supportive evidence for preschool samples; SNAP-IV and CASI-5 are widely used across ages.
Assessing ODD Across the Lifespan
Epidemiology: approximately 10.2% of individuals experience ODD over their lifetime (Nock et al., 2007).
Preschool/early childhood: best-practice approaches do not pathologize normative behavior; can differentiate chronic irritability vs. oppositional behavior; developmentally appropriate interview methods (e.g., PAPA, DISCAP-5) are recommended.
Adult presentations: early work supports reliability/validity of adult ODD measures (e.g., Adult Self-Report of ODD Symptoms; WARA-like measures); overall, DSM-5 criteria can identify ODD in adulthood with reasonable accuracy.
ODD across informants
Parent and teacher reports independently link with broader psychopathology; multi-informant data improve assessment accuracy and prognosis.
Summary for ODD: tetrad of symptoms instead of a single dimension; integration of irritability and noncompliance is crucial for prognosis and treatment planning.
Conduct Disorder (CD)
Diagnostic criteria and prevalence
CD criteria: 15 symptoms across four categories: Aggression to People/Animals; Destruction of Property; Deceit/theft; Serious Violations of Rules.
Must show at least 3 of 15 symptoms within the past year, with at least one symptom in the past 6 months.
Lifetime prevalence of CD is approximately (9.5%).
Limited Prosocial Emotions (LPE) specifier
New in DSM-5 CD: LPE specifier for a subset with callous-unemotional features.
LPE requires at least two of four: lack of remorse or guilt; callousness; unconcerned about performance; shallow or deficient affect; persistent across multiple relationships/settings for at least 12 months.
Evidence supports LPE identifying a distinct subgroup with different prognosis and treatment responsiveness; however, some studies question its utility in all contexts (e.g., some populations, broader psychopathy models).
CD across the lifespan
CD can be diagnosed in preschoolers with LPE using appropriate measures; DISCAP-5 and other DSM-5-aligned tools have demonstrated validity in young children (e.g., 2-year-olds for CD/LPE assessment).
CD can also be diagnosed in adulthood; the APD section discusses the continuity and distinctions between CD with lifetime manifestations and APD.
Diagnostic interviews and measures for CD
DMDD and LPE-related instruments include: Clinical Assessment of Prosocial Emotions (CAPE 1.1); Michigan Limited Prosocial Emotions (M-LPE); DISCAP-5; PSCD (Proposed Specifiers for Conduct Disorder).
PSCD tools provide a multidimensional empathy/psychopathy framework (CU/LPE, grandiose-manipulative, daring-impulsive) but do not cover all CD symptoms; self-report versions validated in various countries.
Rating scales for CD/LPE: CASI-5 (parent/teacher versions); CABI (measures LPE but not CD); PSCD scales (self- and parent-report; for bereft of full CD symptom coverage).
CD across informants and lifespan
Similar to ODD, multi-informant data improve diagnostic validity; cross-informant convergence is not always high but informs clinical risk and treatment needs.
CD-specific cautions and debate
Some argue for broader multidimensional models of psychopathy beyond LPE (to include grandiose-manipulative and daring-impulsive traits).
The AMPD framework and DSM-5 personality disorder approaches inform dimensional assessment of antisocial traits in adults.
Across evidence base: CD assessment emphasizes LPE as a meaningful specifier; strong emphasis on multi-informant, cross-setting observation and developmentally sensitive measurement.
Disruptive Mood Dysregulation Disorder (DMDD)
Conceptualization
DMDD is a depressive-disorder classification in DSM-5, designed to capture chronic irritability and severe temper outbursts in youth; it cannot co-occur with bipolar disorder.
DMDD originated from research on chronic irritability and its distinction from pediatric bipolar disorder.
Diagnostic criteria and prevalence
Two primary symptoms:
Severe and recurrent temper outbursts, at least 3 times per week, with aggression that is developmentally inappropriate.
Persistent irritable or angry mood most of the day, nearly every day, between outbursts.
Symptoms present for at least 12 months, in at least two of three settings (home, school, peers), severe in at least one setting; onset before age 10; diagnosis not before age 6 or after age 18.
Community prevalence estimates range from <1% (0.1%–3.3%) to 7%, with Laporte et al. (2021) converging around ~3%.
DSM-5 excludes DMDD co-occurrence with ODD or IED; if full presentation coexists with either, DMDD is diagnosed alone.
Relationship to other disorders
DMDD often co-occurs with externalizing and internalizing problems and overlaps with ODD symptoms; ICD-11 treats chronic irritability as a subtype within ODD in some contexts.
The DMDD literature has distinct measurement challenges; some tools overlap with irritability and aggression in other disorders.
Assessment approaches and measures
Irritability and outbursts are central symptoms; reliability/validity of measures vary.
Common tools cited for irritability/DMDD assessment include:
Affective Reactivity Index (ARI) and Clinician ARI (CL-ARI)
Aberrant Behavior Checklist irritability subscale (ABC)
Multidimensional Assessment of Preschool Disruptive Behavior (MAP-DB)
Retrospective Modified Overt Aggression Scale (R-MOAS)
Outburst Monitoring Scale (OMS)
Emotional Outburst Inventory (EMO-I)
DMDD measurement remains limited; there is ongoing work on multi-informant, multimethod integration (De Los Reyes et al., 2015; Burke et al., 2020).
DMDD-related development of DMDD-focused interviews is limited; K-SADS-5 includes DMDD/SMD in updated DSM-5 versions.
Lifespan and cross-national considerations
DMDD prevalence and detection show gender differences (some studies suggest male preponderance); cross-national field studies report challenges in reliable DMDD diagnosis across countries.
Ecological momentary assessment (EMA) is a promising method for capturing contextual triggers and frequency/duration of irritability and outbursts in real time.
Summary implications for DMDD assessment
DMDD assessment requires careful differentiation from ODD symptoms and bipolar disorder; emphasize irritability and temper outbursts while considering comorbidity.
There are few validated, DMDD-specific instruments; integration of multi-informant data and developmentally appropriate measures is critical.
Antisocial Personality Disorder (APD)
Diagnostic criteria and context
APD requires 18+ years of age for diagnosis; prior symptoms must have been evident before age 15.
APD features include a pervasive pattern of disregard for and violation of the rights of others, with criteria including several facets such as deceitfulness, impulsivity, aggressiveness, and risk-taking.
In DSM-5, APD sits in both the Personality Disorders section and the Disruptive, Impulse-Control, and Conduct Disorders section, reflecting its overlap with CD.
Relationship to CD
Since CD with LPE specifier exists, the distinction between APD and CD is less clear in adults; some individuals meet criteria for both or transition from CD in youth to APD in adulthood.
Prevalence and associated factors
APD prevalence in adults is estimated around 3%–5% in the U.S., with higher rates in certain populations and domains.
A subset of adults with APD show psychopathy features; this overlap with psychopathy has distinct measurement implications in forensic samples.
Assessment tools and approaches
Multi-informant and multi-method approaches are recommended; collateral informants (e.g., partners, coworkers) can be challenging to obtain but valuable.
Traditional personality assessment tools include:
Personality Diagnostic Questionnaire-4 (PDQ-4)
Personality Assessment Inventory (PAI)
Psychopathy-focused measures are widely used in forensic contexts:
Psychopathy Checklist-Revised (PCL-R)
Triarchic Psychopathy Measure (TriPM)
Psychopathy Personality Inventory-Revised (PPI-R)
PID-5 (DSM-5 trait model) with psychopathy-relevant dimensions
Dimensional frameworks and AMPD
The Alternative Model of Personality Disorders (AMPD) proposes two components: Criterion A (level of personality functioning) and Criterion B (five-domain traits).
When applied to APD, Criterion A includes deficits in prosocial behavior and egocentrism; Criterion B includes traits such as manipulativeness, hostility, deceitfulness, callousness, risk-taking, irresponsibility, and impulsivity; a psychopathy specifier is noted within AMPD discussions.
Measurement considerations
The literature acknowledges potential sex/gender differences in factor structure and predictive validity for violence and reoffending; this warrants careful interpretation in mixed samples.
Intermittent Explosive Disorder (IED)
Diagnostic overview
IED is an impulse-control disorder characterized by frequent, intense, impulsive aggressive outbursts with poor match to preceding stressors; outbursts may be toward people, property, or both.
IED shows high comorbidity with other psychopathologies (ODD, CD, substance use disorder).
Prevalence and onset
Global mean onset around age 17; lifetime prevalence estimates range from roughly .
IED can be diagnosed as young as age 6; longitudinal stability evidence exists but is limited.
Diagnostic and measurement tools
Diagnostic interviews: Structured Clinical Interview for DSM-5 (SCID); SIDP (Structured Interview for DSM-IV Personality Disorders); IED-M (IED Interview-Modified); IED-SQ (IED Screening Questionnaire).
Other supplementary measures for aggression and impulsivity:
Life History of Aggression (LHA)
Buss-Perry Aggression Questionnaire (BPAQ)
State-Trait Anger Expression Inventory-II (STAX-II)
Hostile Automatic Thoughts (HAT) scale
Overt Aggression Scale Modified (OAS-M)
Measurement considerations and gaps
There are relatively few IED-specific diagnostic tools validated for clinical settings; much reliance on research instruments (SCID, SIDP, IED-M) with limited evidence for clinical utility of some tools (e.g., IED-SQ not validated in clinical settings).
OAS-M has been used in clinical trials and can track change in aggressive symptoms during treatment; more work is needed to establish cross-clinical validity.
Future directions
There is a need for brief, psychometrically strong, multi-informant measures of IED, especially for children and adolescents.
Emphasis on diverse samples and cross-informant data to improve generalizability of IED assessment and its treatment implications.
DMDD, ODD, CD, APD, IED: Cross-Disorder Considerations
DMDD and ODD relationship
DMDD overlaps with ODD in irritability and temper outbursts; measurement strategies need to distinguish chronic irritability from oppositional/defiant behavior.
Some developmentally tailored measures may inadvertently conflate irritability and oppositionality; careful item design is needed in DMDD-focused instruments.
ICD-11 vs DSM-5 approaches
ICD-11 offers irritability-based subtypes for certain presentations and may diverge from DSM-5 in how irritability is classified, highlighting the importance of cross-diagnostic research.
Dimensional versus categorical pathways
While categorical diagnoses support clinical decision-making and guideline concordance, dimensional models may capture heterogeneity and trajectories better; the evidence is mixed and context-dependent.
Informant integration and multi-method approaches
The consensus underscores using multiple informants and methods (interviews plus rating scales) across development stages and disorders to maximize validity.
Cross-cultural and lifespan considerations
Cross-cultural validity of DMDD and irritability measures remains a key research area; field studies show some challenges in cross-national reliability.
Across the lifespan, tools for adults with DBDs (e.g., APD) are developing, with special attention to AMPD framework and psychopathy-related measures.
Assessment Tools: Tables 1 and 2 (Representative Examples)
Table 1: Assessment Tools for ODD, CD, and LPE
Interviews (examples):
CAPA (Child and Adolescent Psychiatric Assessment)
CHIPS (Children’s Interview for Psychiatric Syndromes)
DAWBA (Developmental and Well-Being Assessment)
DICA-PPYC (Diagnostic Interview for Children and Adolescents for Parents of Preschool and Young Children)
DIPA (Diagnostic Infant and Preschool Assessment)
DISCAP-5 (Diagnostic Interview Schedule for Children Adolescents and Parents 5)
K-SADS-PL-5 (Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version, DSM-5)
MINI-KID (Mini International Neuropsychiatric Interview for Kids)
PAPA (Preschool Age Psychiatric Assessment)
WRAADS (Wender-Reimherr Adult ADHD Scale)
LPE measures: CAPE (Clinical Assessment of Prosocial Emotions), M-LPE (Michigan Limited Prosocial Emotions)
Rating scales (examples):
ABI-YA (Antisocial Behavior Index for Young Adulthood)
ASROS-5 (Adult Self-Report of ODD Symptoms for DSM-5)
CABI (Child and Adolescent Behavior Inventory)
CASI-5 (Child and Adolescent Symptom Inventory)
DBDRS (Disruptive Behavior Disorder Rating Scale)
K-CAT (K-CAT)
NICHQ Vanderbilt Scales
SNAP-IV
CD & LPE measures: CPTI (Child Problematic Traits Inventory), PSCD (Proposed Specifiers for Conduct Disorder)
Table 2: Assessment Tools Related to DMDD, APD, and IED
DMDD: ARI, CL-ARI, ABC, MAP-DB, R-MOAS, OMS, EMO-I
APD: PDQ-4, PAI; PCL-R (psychopathy), TriPM, PPI-R, PID-5
IED: SCID, SIDP, IED-M, IED-SQ, LHA, BPAQ, STAX-II, HAT, OAS-M
Note: Many measures have been updated or designed for DSM-5; some measures were originally DSM-IV and later updated.
Assessment Across the Lifespan and Cross-Cultural Considerations
Lifespan notes
ODD can be identified in preschoolers with developmentally appropriate interviews; validity of DMDD and irritability measures has grown but requires caution in younger populations.
In adulthood, some ODD-like symptoms and CD/LPE features can be observed; several adult-oriented measures (e.g., ARI-based and adult psychopathy tools) exist but require careful interpretation.
Cross-cultural considerations
International field studies show variability in diagnostic performance for DMDD and irritability; cross-national measurement work is ongoing.
Cross-cultural data emphasize the need for culturally valid instruments and measurement invariance across populations.
Implications for practice
Clinicians should pursue a broad, multi-method approach with multiple informants to accommodate context-specific behavior and reduce misdiagnosis due to bias.
Clinicians should maintain a careful balance between recognizing clinically meaningful symptoms and avoiding over-pathologizing normative development, especially in preschoolers.
Conclusions and Practical Takeaways
The central guidance: follow DSM-5 diagnostic guidelines closely and use a broad, evidence-based assessment approach that combines interviews, rating scales, and structured diagnostic tools, ideally across multiple informants.
The benefits of a robust assessment include improved accuracy, more precise differential diagnosis, better treatment planning, and the ability to build a stronger educational/clinical support plan for the child or adult.
Ongoing needs in the field:
More empirical work on stigma related to DBD diagnoses and its real-world costs/benefits.
More reliable cross-cultural measurement tools for DMDD and irritability; better multi-informant integration methods, particularly for DMDD and IED in youth.
Further development and validation of brief, multi-informant measures for IED and APD across diverse populations.
Final exhortation: diagnoses describe problems and guide treatment, not define the person; careful and transparent diagnostic processes maximize treatment planning and outcomes.
References and Context (Selected)
DSM-5 and DSM-5-TR updates; ICD-11 considerations.
Foundational texts and key studies cited include, among others: Lahey (2021) on dimensional classifications; Wakschlag et al. (2017) on irritability dimensions; multiple validation studies for K-SADS-PL-5, CAPA, DISCAP-5; MI/-AMDP discussions for APD; cross-cultural DMDD debates; and systematic reviews on assessment tools (Walker et al., 2020; Murkner-Lavanchy et al., 2021).
Core data points: prevalence estimates (ODD ~10%; CD ~9.5%; DMDD 0.1%–7%); onset ages; reliability indices (ODD interview kappa values); and multi-informant advantages/limitations.